100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
P Nolzine 500mg Tablet SR 10s
Pacific Meditech Pvt. Ltd.
₹190
Our Recommendation
Ranoright 500mg ER Tablet 10s
4,034+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Angina (heart-related chest pain)
Customers also bought
More About P Nolzine 500mg Tablet SR 10s
Benefits
In Angina (heart-related chest pain) P-Nolzine 500mg Tablet SR reduces the oxygen requirement of the heart and relaxes the heart muscles. It makes sure that your heart is able to perform its functions in the amount of oxygen supply available without causing stress on heart muscles. This makes it less likely that you will suffer chest pain caused by angina. This medicine can help increase your ability to exercise and go about your daily life more easily by reducing the frequency of angina attacks. You should take it regularly and as long as it is prescribed for it to work effectively.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. P-Nolzine 500mg Tablet SR is to be taken with food.
How it works
P-Nolzine 500mg Tablet SR is an anti-anginal medication. It works by decreasing the oxygen requirement of the heart by relaxing heart muscle.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with P-Nolzine 500mg Tablet SR . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: P-Nolzine 500mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: P-Nolzine 500mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Seek medical advice from your doctor: It is not known whether P-Nolzine 500mg Tablet SR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Caution Advised: P-Nolzine 500mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of P-Nolzine 500mg Tablet SR may be needed. Doctor consultation is advised. Use of P-Nolzine 500mg Tablet SR is not recommended in patients with severe kidney disease.
Caution Advised: P-Nolzine 500mg Tablet SR should be used with caution in patients with liver disease. Dose adjustment of P-Nolzine 500mg Tablet SR may be needed. Doctor consultation is advised. Use of P-Nolzine 500mg Tablet SR is not recommended in patients with moderate to severe liver disease.
What if I forget to take it?
If a dose of P-Nolzine 500mg Tablet SR is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Office No - 3, Plot No B-64, Kh No - 371, Bawana Road Shahbad Daulatpur North West DL 110042 INDIA
References
Opie LH, Horowitz JD. Nitrates and Newer Antianginals ?-Blocking Agents. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 56
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1200
Ranolazine. Wooburn Green, Buckinghamshire: A. Menarini Farmaceutica Internazionale SRL; 2008 (25 Jan. 2019)
Ranolazine. Foster City, California: Gilead Sciences, Inc.; 2013 (20 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Ranolazine Sustained Release Tablets (25 Jul. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
